Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bouwman

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2013
Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancerChristian Bowman-Colin, Bing Xia, Samuel Bunting, et al.
Cancer Discovery|April 25, 2019
PARP Inhibitor Efficacy Depends on CD8<sup>+</sup> T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast CancerConstantia Pantelidou, Olmo Sonzogni, Mateus De Oliveria Taveira, et al.
Nature Structural & Molecular Biology|May 11, 2010
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancersPeter Bouwman, Amal Aly, Jose M Escandell, et al.
Biochemical Pharmacology|May 6, 2021
Integration of temporal single cell cellular stress response activity with logic-ODE modeling reveals activation of ATF4-CHOP axis as a critical predictor of drug-induced liver injuryLukas Surya Wijaya, Panuwat Trairatphisan, Attila Gabor, et al.
Archives of Toxicology|September 4, 2021
Fluorescent tagging of endogenous Heme oxygenase-1 in human induced pluripotent stem cells for high content imaging of oxidative stress in various differentiated lineagesKirsten E Snijders, Anita Fehér, Zsuzsanna Táncos, et al.
EMBO Molecular Medicine|July 22, 2017
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicityEliana Mc Tacconi, Xianning Lai, Cecilia Folio, et al.
Cell Reports|August 27, 2020
Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End JoiningPaola Francica, Merve Mutlu, Vincent A Blomen, et al.
Breast Cancer Research : BCR|June 17, 2022
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancerLeonie Ratz, Chiara Brambillasca, Leandra Bartke, et al.
The Journal of Experimental Medicine|July 17, 2013
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survivalChiara Gorrini, Pegah S Baniasadi, Isaac S Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2019
EZH2 Is Overexpressed in <i>BRCA1</i>-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based ChemotherapyJulian Puppe, Mark Opdam, Philip C Schouten, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2013
Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancerChristian Bowman-Colin, Bing Xia, Samuel Bunting, et al.
Cancer Discovery|April 25, 2019
PARP Inhibitor Efficacy Depends on CD8<sup>+</sup> T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast CancerConstantia Pantelidou, Olmo Sonzogni, Mateus De Oliveria Taveira, et al.
Nature Structural & Molecular Biology|May 11, 2010
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancersPeter Bouwman, Amal Aly, Jose M Escandell, et al.
Biochemical Pharmacology|May 6, 2021
Integration of temporal single cell cellular stress response activity with logic-ODE modeling reveals activation of ATF4-CHOP axis as a critical predictor of drug-induced liver injuryLukas Surya Wijaya, Panuwat Trairatphisan, Attila Gabor, et al.
Archives of Toxicology|September 4, 2021
Fluorescent tagging of endogenous Heme oxygenase-1 in human induced pluripotent stem cells for high content imaging of oxidative stress in various differentiated lineagesKirsten E Snijders, Anita Fehér, Zsuzsanna Táncos, et al.
EMBO Molecular Medicine|July 22, 2017
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicityEliana Mc Tacconi, Xianning Lai, Cecilia Folio, et al.
Cell Reports|August 27, 2020
Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End JoiningPaola Francica, Merve Mutlu, Vincent A Blomen, et al.
Breast Cancer Research : BCR|June 17, 2022
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancerLeonie Ratz, Chiara Brambillasca, Leandra Bartke, et al.
The Journal of Experimental Medicine|July 17, 2013
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survivalChiara Gorrini, Pegah S Baniasadi, Isaac S Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2019
EZH2 Is Overexpressed in <i>BRCA1</i>-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based ChemotherapyJulian Puppe, Mark Opdam, Philip C Schouten, et al.
Pageof 5